Abstract
Alterations in lipid metabolism have the potential to be markers as well as drivers of pathobiology of acute critical illness. Here, we took advantage of the temporal precision offered by trauma as a common cause of critical illness to identify the dynamic patterns in the circulating lipidome in critically ill humans. The major findings include an early loss of all classes of circulating lipids followed by a delayed and selective lipogenesis in patients destined to remain critically ill. The previously reported survival benefit of early thawed plasma administration was associated with preserved lipid levels that related to favorable changes in coagulation and inflammation biomarkers in causal modelling. Phosphatidylethanolamines (PE) were elevated in patients with persistent critical illness and PE levels were prognostic for worse outcomes not only in trauma but also severe COVID-19 patients. Here we show selective rise in systemic PE as a common prognostic feature of critical illness.
Introduction
Acute critical illness—whether triggered by severe physical trauma or infections like COVID-19—initiates a complex and often chaotic host response involving widespread inflammation, immune suppression, and multi-organ dysfunction. A significant clinical challenge lies in predicting which patients will recover quickly and which will face prolonged illness or mortality. While lipids are known to be essential for cellular structure, energy storage, and immune signaling, their global dynamic shifts during critical illness have remained poorly understood. By using severe trauma as a model—where the exact time of injury is known with precision—researchers have mapped the metabolic collapse and subsequent recovery patterns of the human lipidome.
Methods
The study utilized longitudinal blood plasma samples from the PAMPer Trial, involving 193 severe trauma patients and 17 healthy controls. Samples were collected at admission (0h), 24h, and 72h.
The researchers employed targeted lipidomics via Liquid Chromatography-Mass Spectrometry (LC-MS/MS) to quantify 996 distinct lipid species across 14 classes. Data analysis involved dimensionality reduction (UMAP, PCA) to visualize global shifts and causal inference modeling to explore relationships between interventions, lipid levels, and outcomes. Finally, a Lipid Reprogramming Score (LRS) was developed using LASSO feature selection and Support Vector Machines (SVM), focusing on five specific phosphatidylethanolamine (PE) species. Validation was performed using an independent trauma cohort and two public COVID-19 datasets.
Key Insights and Results
The Hyperacute Lipid Crash and Plasma Rescue
A defining feature of the immediate post-trauma period is a dramatic, systemic drop in all classes of circulating lipids. This "energy substrate crisis" suggests the body rapidly depletes circulating fats to survive initial shock. The severity of this drop strongly correlates with early mortality.
Interestingly, the administration of thawed plasma (TP) during pre-hospital transport—previously shown to improve survival—was found to mitigate this lipid crash. Causal modeling linked preserved lipid levels to improved coagulation and reduced systemic inflammation.
Delayed Lipid Reprogramming
In patients with non-resolving critical illness, a secondary phase of "lipid reprogramming" occurs by 72 hours. This phase is characterized by a selective increase in triglycerides (TAG), diacylglycerols (DAG), and specifically phosphatidylethanolamines (PE). This signature appears to be a universal stress response, as the same PE elevations were observed in severe COVID-19 patients, independent of the initial cause of illness.
Prognostic Value of the Lipid Reprogramming Score (LRS)
The LRS proved to be a powerful independent predictor of poor outcomes. In trauma patients, adding the LRS to standard clinical models significantly improved predictive accuracy (AUC increased from 0.798 to 0.816). In COVID-19 patients, a high LRS was associated with a nearly tenfold increase in the odds of severe disease (OR 9.88), outperforming traditional markers like C-reactive protein (CRP) and lymphocyte counts.
Discussion
This study identifies systemic lipid depletion followed by selective PE elevation as a hallmark of failing to resolve critical illness. While the study provides high-resolution insights, it is limited by a lack of correlation with standard clinical lipid panels and the exclusion of certain lipid mediators like resolvins. Future research should focus on prospective validation of the LRS and exploring the specific metabolic origins of these circulating lipid shifts in other conditions like sepsis or burns.
Summary updated